Devices and Drugs

Embed Size (px)

Citation preview

  • 7/30/2019 Devices and Drugs

    1/43

    INHALED MEDICATIONS AND DRUGS FOR

    ASTHMA AND COPD

    DR. VISHNU SHARMA .M.

    PROFESSOR AND HEADDEPT OF PULMONARY MEDICINE

    A. J. INSTITUTE OF MEDICAL SCIENCES

    MANGALORE

  • 7/30/2019 Devices and Drugs

    2/43

    WHY INHALED MEDICATION

    Inhaled

    Small amount of dosage used

    Lesser side effects

    Fast onset of action(e.g. bronchodilators)

    Useful in acute symptoms

    ORAL

    Large dosage used

    Greater side effects

    Slow onset of action

    Not useful in acute symptoms

  • 7/30/2019 Devices and Drugs

    3/43

    Devices

    MDI

    DPI

    NEBULIZER

  • 7/30/2019 Devices and Drugs

    4/43

  • 7/30/2019 Devices and Drugs

    5/43

    The Best route for Asthma and COPD

    Medication is the

    Inhaled Route

    The same holds true for

    ACUTE ASTHMA ATTACK and AECOPD

  • 7/30/2019 Devices and Drugs

    6/43

    Why Nebulisation

    Immediate relief is requiredwhich can be achieved only

    from inhalation therapy.

    Patient is critical hence unable

    to co-ordinate with inhaled

    devices.

    Nebulisation is the best resort

    to give optimal dose and

    targeted drug delivery

  • 7/30/2019 Devices and Drugs

    7/43

    Nebulizer

    Fill volume-2 to 4ml

    Time 8-10mt

    End point-Spluttering sound

    O2 flow rate 6-8li/mt

  • 7/30/2019 Devices and Drugs

    8/43

    Instructions to the Patient

    Sit upright

    Take normal steady breaths

    Breath hold if possible for 5-8 seconds

    Not to talk during the nebulisation

  • 7/30/2019 Devices and Drugs

    9/43

    Mask / Mouth piece

    Mask for those who cant co-operate

    Mouthpiecesless chance to eye irritation

  • 7/30/2019 Devices and Drugs

    10/43

    Precautions

    Aseptic precautions to prevent infection

    Proper disinfection

    Hand hygiene

  • 7/30/2019 Devices and Drugs

    11/43

    Respule/Respiratory solution

    Respule -ready to use

    Respiratory solution needs to be diluted

    Respule cost is more

  • 7/30/2019 Devices and Drugs

    12/43

    RESPIRATORY SOLUTION RESPULE

  • 7/30/2019 Devices and Drugs

    13/43

    Metered dose inhaler

    Quick to use

    Compact

    Disadvantage

    Technique is difficult

  • 7/30/2019 Devices and Drugs

    14/43

  • 7/30/2019 Devices and Drugs

    15/43

    Why use a Spacer ?

    Ensures correct use of an MDI by

    correcting co-ordination problems.

    Reduces incidence of throat infections

    with inhaled steroid

    As good as nebuliser for acute

    exacerbations ( with MDI )

  • 7/30/2019 Devices and Drugs

    16/43

    Then do we need nebulizers ?

    YES

    Acute severe asthma with impendingrespiratory failure

    Intensive care / Hospital / Clinic /Ambulances

  • 7/30/2019 Devices and Drugs

    17/43

    Easy to use

    Compact

    More oropharyngeal deposition

    Dry powder inhaler

  • 7/30/2019 Devices and Drugs

    18/43

    Which inhalation Device?

    Inhalers

    MDI DPI Nebuliser

    (acute severe

    episodes only)

  • 7/30/2019 Devices and Drugs

    19/43

  • 7/30/2019 Devices and Drugs

    20/43

  • 7/30/2019 Devices and Drugs

    21/43

    When you can not use a DPI?

    Patient not able to inhale-Child below 3, or Elderly

    Use:

    MDI + Spacer

    MDI + Spacer + Baby Mask

  • 7/30/2019 Devices and Drugs

    22/43

    Disadvantages OF Inhaled medications

    Needs patient co-operation

    Technique should be correct

    Oropharyngeal deposition

    Irritation to eye with nebulization

  • 7/30/2019 Devices and Drugs

    23/43

    Inhalation Drugs in Asthma and COPDBeta 2 agonists

    Anti cholinergics

    Gluco-corticosteroids

  • 7/30/2019 Devices and Drugs

    24/43

    Long acting beta agonists

    Salmeterol

    Formoterol

    Indacaterol

    Arfomoterol

    Bambuterol

  • 7/30/2019 Devices and Drugs

    25/43

    Formetrol

    Rapid onset of action

    Short duration of side effect

    Response increase with dose

    No cumulative side effect.

  • 7/30/2019 Devices and Drugs

    26/43

    Salmetrol

    Slower onset

    Long duration of side effect

    No such effect

    Cumulative side effect

  • 7/30/2019 Devices and Drugs

    27/43

    ADVERSE EFFECTS

    Uncommon with inhalation

    Tremor, dyspnoea, weakness, headache

    Palpitations, tachycardia, arrhythmias

    Tolerance

    Hypokalemia with high doses

  • 7/30/2019 Devices and Drugs

    28/43

    PRECAUTIONS

    Use with cautions in patients with diabetes,hypertension

    Severe paradoxical bronchoconstr iction

    Administered cautiously in cardiac patients

  • 7/30/2019 Devices and Drugs

    29/43

    DRUG INTERACTIONS

    Combination of salmeterol - f luticasone &

    formoterol-budesonide have synergistic

    action

    I ncreased risk of hypokalemia with high dose

    of corticosteroid with2 agonists

  • 7/30/2019 Devices and Drugs

    30/43

    Anticholinergic drugs

    Ipratropium bromide is a quaternary

    ammonium derivative of atropine.

    Tiotropium bromide the most recently

    developed, has a longer duration of action.

  • 7/30/2019 Devices and Drugs

    31/43

    AdvantagesMinor side effects

    Used in COPD

  • 7/30/2019 Devices and Drugs

    32/43

    Disadvantages

    Slow onset of action

    Less effective than2 agonist

    No anti -inf lammatory action

  • 7/30/2019 Devices and Drugs

    33/43

    High topical low systemic activity

    Suppress bronchial inflammation, increase peak

    expiratory flow rate

    Inhaled corticosteroids

  • 7/30/2019 Devices and Drugs

    34/43

    Modulation of cytokine and chemokine production

    Inhibition of eicosanoid synthesis

    Inhibition of accumulation of leucocytes in the lungs

    Decreased vascular permeability

    Mechanism of action

  • 7/30/2019 Devices and Drugs

    35/43

    MDIs

    DPIs

    Nebulization

    Methods of administration

  • 7/30/2019 Devices and Drugs

    36/43

    Equivalent dosages

    E i l d

  • 7/30/2019 Devices and Drugs

    37/43

    200mg beclomethasone

    200mcg budesonide

    80mcg cic lesom ide

    100mcg f lut icasone

    200mcg mometasone

    Equivalent dosages

  • 7/30/2019 Devices and Drugs

    38/43

    Beclomethasone

    Budesonide

    Flut icasone

    Ciclesonide

    Mometasone

    Preparations

  • 7/30/2019 Devices and Drugs

    39/43

    Hoarseness- steroid induced myopathy

    Dysphonia

    Oropharyngeal candidiasis

    LOCAL Adverse effects

  • 7/30/2019 Devices and Drugs

    40/43

    Systemic Adverse effects Mood changes

    Osteoporosis

    Bruising, hyperglycemia

    HPA suppression

    Ad ff t

  • 7/30/2019 Devices and Drugs

    41/43

    HPA suppression- dosages above 1500mcg of

    beclomethasone

    Children 400mcg beclomethasone

    Children with asthma even though there may be pre-

    pubertal growth delay, they tend to catch up later

    Thinning of skin and striae especially elderly

    Adverse effects- concerns

  • 7/30/2019 Devices and Drugs

    42/43

    ICS+LABA

    Potentiate each other

    Equivalent to double the dosage of steroid

    Interactions

  • 7/30/2019 Devices and Drugs

    43/43

    THANK YOU